Acta Angiologica
Scope & Guideline
Advancing Vascular Health Through Open Access Research
Introduction
Aims and Scopes
- Vascular Disease Management:
The journal emphasizes the prevention, diagnosis, and treatment of vascular diseases, including atherosclerosis, venous thromboembolism, and peripheral artery disease. - Innovative Therapeutic Approaches:
Research into new therapeutic modalities, such as endovascular techniques, laser therapies, and pharmacological interventions, is a significant focus, highlighting advancements in treatment strategies. - Clinical and Translational Research:
Acta Angiologica publishes studies that bridge laboratory research and clinical practice, reflecting on the implications of findings for patient care and management. - Systematic Reviews and Meta-Analyses:
The journal frequently features systematic reviews and meta-analyses that synthesize existing research, providing valuable insights into best practices and emerging trends in vascular health. - Multi-disciplinary Collaboration:
The journal encourages collaboration across various fields, including cardiology, surgery, and pharmacology, to foster a comprehensive understanding of vascular health.
Trending and Emerging
- Endovascular Innovations:
There has been a significant increase in studies related to endovascular techniques and innovations, reflecting advancements in minimally invasive approaches to vascular interventions. - Impact of Systemic Conditions on Vascular Health:
Growing attention is being paid to the interplay between systemic conditions such as diabetes, obesity, and cardiovascular diseases, and their impact on vascular health and outcomes. - Immunological Factors in Vascular Diseases:
Emerging research is focusing on the role of immune responses in the pathogenesis of vascular diseases, indicating a shift towards understanding the inflammatory aspects of these conditions. - Patient-Centric Approaches:
There is an increasing trend towards research that emphasizes patient outcomes, quality of life, and individualized treatment strategies, highlighting the importance of patient perspectives in vascular care. - Biomarkers and Predictive Models:
The exploration of new biomarkers for vascular diseases and predictive models for treatment outcomes is on the rise, reflecting an interest in precision medicine within vascular health.
Declining or Waning
- Traditional Surgical Techniques:
Papers focusing solely on traditional surgical approaches to vascular diseases have decreased, as newer, less invasive techniques gain traction. - Basic Science Studies:
Research that primarily explores basic science without direct clinical implications appears to be waning, reflecting a shift towards more clinically relevant studies. - Historical Perspectives:
There is a noticeable reduction in publications that focus on historical analyses or reviews of older therapies, suggesting less interest in retrospective examinations. - Single-Center Studies:
The prevalence of single-center studies has diminished, as there is a growing preference for multi-center collaborations that enhance the generalizability of findings. - Non-invasive Diagnostic Techniques:
Research on non-invasive diagnostic methods, while still relevant, has seen a decline, with a growing focus on advanced imaging techniques and their clinical applications.
Similar Journals
Indian Journal of Vascular and Endovascular Surgery
Innovating Vascular Solutions for Better OutcomesThe Indian Journal of Vascular and Endovascular Surgery, published by Wolters Kluwer Medknow Publications, serves as a premier platform dedicated to advancing research and clinical practices in the fields of vascular and endovascular surgery. With an E-ISSN of 2394-0999 and a commitment to open access since 2015, this journal provides invaluable insights to researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of knowledge. By focusing on innovative techniques, case studies, and systematic reviews, the journal plays a vital role in enhancing clinical outcomes and promoting evidence-based practices within the vascular community. Its commitment to high-quality research and accessibility positions it as an essential resource in the landscape of surgical literature, encouraging further exploration and collaboration within this critical area of healthcare.
Clinical Medicine Insights-Cardiology
Exploring Cutting-Edge Research in Cardiovascular HealthClinical Medicine Insights-Cardiology is a prestigious open-access journal published by SAGE Publications Ltd, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. With the ever-evolving landscape of cardiovascular health, this journal serves as a vital platform for disseminating significant findings, clinical practices, and innovative therapies. Established in 2007, it has rapidly gained recognition, currently ranked in the Q2 category for cardiology, positioned at #112 out of 387 in Scopus Rankings, and boasting a commendable 71st percentile. The journal not only emphasizes the integration of recent advancements in clinical and laboratory studies but also aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. Situated in New Zealand and operating with an open-access model, Clinical Medicine Insights-Cardiology promotes the unrestricted dissemination of knowledge, ensuring that critical insights into cardiovascular medicine are accessible globally.
INTERNATIONAL ANGIOLOGY
Shaping the Future of Cardiology with Pioneering StudiesINTERNATIONAL ANGIOLOGY is a leading journal in the field of Cardiology and Cardiovascular Medicine, published by EDIZIONI MINERVA MEDICA. Since its inception in 1984, it has become an essential resource for researchers, clinicians, and students interested in the latest advancements and research in vascular health. With an ISSN of 0392-9590 and an E-ISSN of 1827-1839, the journal maintains a strong academic presence, reflected by its category quartile ranking of Q3 in 2023, positioning it among the noteworthy publications within the cardiology sector, as indicated by its Scopus rank of #209 out of 387. Although the journal is not open access, it provides a critical platform for disseminating knowledge on topics ranging from angiogenesis to interventional vascular procedures. As the journal continues to evolve towards its convergence in 2024, it remains committed to fostering academic discourse and delivering high-quality research that shapes the future of cardiovascular medicine.
Diabetes & Vascular Disease Research
Exploring the vital connections between diabetes and cardiovascular disease.Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.
Journal of Atherosclerosis and Thrombosis
Shaping the future of cardiovascular care with cutting-edge insights.Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.
ANNALS OF VASCULAR SURGERY
Advancing Vascular Knowledge for Tomorrow's SurgeonsANNALS OF VASCULAR SURGERY is a premier journal published by Elsevier Science Inc, focusing on the rapidly evolving field of vascular surgery and its related disciplines. With a notable impact factor reflected in its 2023 Q2 rankings in Cardiology and Cardiovascular Medicine, as well as in Medicine and Surgery, this journal stands out as a reputable source for cutting-edge research and clinical practices. Since its inception in 1986, it has aimed to advance knowledge, foster innovation, and enhance surgical techniques through comprehensive reviews, original research articles, and clinical trials. Although not currently adopting an open access model, the journal continues to serve as a crucial repository of information for researchers, clinicians, and students, facilitating the dissemination of clinical and scientific advancements in vascular health. As it converges through the years towards 2024, the ANNALS OF VASCULAR SURGERY is poised to remain a valuable resource for the global medical community.
Vascular Specialist International
Enhancing clinical practices for better patient outcomes worldwide.Vascular Specialist International, published by the Korean Society of Vascular Surgery, serves as a pivotal platform in the field of vascular surgery and cardiovascular medicine. With an Open Access policy established since 2014, the journal encourages a broader dissemination of research findings to an international audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal, ISSN 2288-7970, is headquartered in South Korea and spans a significant publication back to its inception, focusing on advancing clinical practice and research in vascular health. In the 2023 rankings, it is positioned in quartile Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, reflecting its growing impact within the scientific community. Furthermore, it holds commendable Scopus rankings in both categories, indicating its relevance and contributions to the field. With a mission to enhance vascular surgery practices and improve patient outcomes worldwide, Vascular Specialist International stands as an essential resource for those dedicated to advancing the science and art of vascular healthcare.
ANGIOLOGY
Exploring the Future of Cardiovascular CareANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.
Italian Journal of Vascular and Endovascular Surgery
Bridging research and practice in vascular surgery.Italian Journal of Vascular and Endovascular Surgery, published by EDIZIONI MINERVA MEDICA, serves as a pivotal platform in the realm of vascular and endovascular surgical research in Italy and beyond. With an ISSN of 1824-4777 and an E-ISSN of 1827-1847, this journal spans a decade of scholarly contributions from 2004 to 2024. Although currently categorized in the Q4 quartile within both Cardiology and Cardiovascular Medicine and Surgery, with Scopus ranks reflecting its growing recognition in the scientific community, it continues to foster advancements in the understanding and treatment of vascular diseases. The journal is dedicated to publishing innovative research, clinical studies, and comprehensive reviews that empower professionals and enrich the education of students in the vascular surgery field. While currently not offering open access, it remains an essential resource for those seeking to stay abreast of the latest developments and practices in vascular and endovascular surgery.
VASCULAR PHARMACOLOGY
Connecting research and practice in vascular medicine.Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.